MarketScreener Editorial Features Vaxcyte, Inc.
Equities
PCVX
US92243G1085
Biotechnology & Medical Research
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
84.76 USD | -1.37% |
|
-2.35% | +3.21% |
Feb. 07 | Vaxcyte Insider Sold Shares Worth $450,369, According to a Recent SEC Filing | MT |
Feb. 05 | Vaxcyte Advances Phase 2 Study on Infant Pneumococcal Disease Prevention to Final Stage | MT |
- Stock Market
- Equities
- PCVX Stock
- News Vaxcyte, Inc.
- MarketScreener Editorial Features